Corpus Intelligence IC Memo — HIGHLAND SPRINGS 2026-04-27 00:04 UTC
IC Memo — HIGHLAND SPRINGS
Investment Committee Memorandum | OH | 72 beds | Grade D | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 364053

HIGHLAND SPRINGS

LOCATIONCUYAHOGA, OH·BEDS72·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

HIGHLAND SPRINGS is a 72-bed under-performing / distressed in CUYAHOGA, OH with $18.6M in net patient revenue and a -43.1% operating margin. The hospital serves a payer mix of 6.2% Medicare, 0.3% Medicaid, and 93.5% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -43.1% to -35.7% (+736bps).

Net Revenue HCRIS$18.6M
Current EBITDA COMPUTED$-8.0M
Operating Margin COMPUTED-43.1%
Occupancy HCRIS81.6%
Revenue / Bed COMPUTED$259K
Net-to-Gross HCRIS26.1%
Distress Probability ML39.9%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
94
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -43.1% places it below the state median. Among 94 size-comparable peers (36-144 beds), the median margin is 1.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-144), prioritizing same-state peers. 94 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HIGHLAND SPRINGS (Target)OH72$18.6M-43.1%
DUBLIN METHODIST HOSPITALOH110$333.9M28.4%
SOIN MEDICAL CENTEROH120$256.3M-1.3%
LIMA MEMORIAL HOSPITALOH110$253.5M6.4%
UH REGIONAL HOSPITALSOH144$214.6M-21.6%
UH ST. JOHN MEDICAL CENTEROH126$210.9M6.5%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
ST. JOSEPH HEALTH CENTEROH135$194.2M5.8%
UH GEAUGA MEDICAL CENTEROH106$183.3M6.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$391K+210bp18mo
Cost to Collect4.5%2.5%$373K+200bp12mo
Denial Rate Reduction12.0%6.5%$369K+198bp12mo
A/R Days Reduction5200.0%3800.0%$227K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$391K
Cost to Collect
$373K
Denial Rate Reduction
$369K
A/R Days Reduction
$227K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$-8.0M
+ RCM Uplift+$1.4M
Pro Forma EBITDA$-6.7M
Current Margin-43.1%
Pro Forma Margin-35.7%
WC Released (1x)$715K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.4M$-39.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.4M$-47.2M0.00x-100.0%
Bull Case9.0x11.0x$-11.1M$-46.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.1M$-54.2M0.00x-100.0%
Bear Case11.0x10.0x$-13.6M$-42.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.6M$-50.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 94 hospitals with 36-144 beds
  • Same-state prioritization (n=95)
  • Comp margins: P25=-13.8% / P50=1.4% / P75=9.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.